What is STREAM?

STREAM is a collaboration of researchers who share a common set of principles about the goals and methods for studying clinical translation. We apply empirical and philosophical tools for addressing scientific, ethical, and policy challenges in the development and translation of health technologies. Our members work in ethics, epidemiology, biology, psychology, and various medical specialties. The network is centered at McGill University, and has affiliates throughout North America and abroad.

Our Latest Publications

Kimmelman J, Tannock, I. The paradox of precision medicine. Nature Reviews Clinical Oncology, April 19, 2018.

Our Latest Publications

London A, Kimmelman J. Clinical Trials in Medical Center Advertising, JAMA Oncology, April 5, 2018.

Our Latest Publications

Carlisle B, Federico C, Kimmelman J. Trials that say “maybe”: the disconnect between exploratory and confirmatory testing after drug approval, The BMJ, March 20, 2018.

Our Latest Publications

Marcin Waligora, Malgorzata M. Bala , Magdalena Koperny, Mateusz T. Wasylewski, Karolina Strzebonska, Rafał R. Jaeschke, Agnieszka Wozniak, Jan Piasecki, Agnieszka Sliwka, Jerzy W. Mitus, Maciej Polak, Dominika Nowis, Dean Fergusson, Jonathan Kimmelman. Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis. PLoS Medicine. February 2018.

News

Science coverage of research co-authored by doctoral candidate Carole Federico and Jonathan Kimmelman, on reliability of animal efficacy data.

HealthNewsReview.org publishes article covering Alex John London and Jonathan Kimmelman's recent publication in JAMA Oncology; additional coverage on Medscape.

Jonathan Kimmelman quoted in National Post, on why patients deserve post-trial access to drugs they appear to have benefited from.

Jonathan Kimmelman quoted in STAT News, about his recent publication in PLoS Medicine.

Jonathan Kimmelman quoted in Medical Republic article on animal studies and translational research.

Can cancer researchers accurately judge whether preclinical reports will reproduce? described as one of the biggest media hits at PLoS Bio for 2017.

Jonathan Kimmelman in Bloomberg News article about CRISPR.

STAT News coverage of recent research from Jonathan Kimmelman and colleagues showing that cancer experts are not very accurate at forecasting results of clinical trials.

Jonathan Kimmelman quoted in CBC News: "Should we let the crowd fund Canadian science if no one else will?"

The BMJ, MedPage Today, and the Telegraph quote Jonathan Kimmelman in their coverage of failed TB vaccine trial.

All content © STREAM research

admin@translationalethics.com
Twitter: @stream_research
3647 rue Peel
Montreal QC H3A 1X1